NEW YORK, Jan. 26, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX) today announced the commercial launch of BRIUMVI™ (ublituximab-xiiy), for the treatment of relapsing forms of multiple ...
Telguard’s TG-7E commercial intrusion communicator is fully compliant with all applicable UL and ULC standards for dual path, backup and SLS communicators in the U.S. and Canada. Part of the full line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback